Randomized Angioplasty Beta Blocker Intracoronary Trial II - RABBIT II – Presented at AHA 2006

Description:

The goal of the trial was to evaluate the use of intracoronary (IC) administration of the beta-blocker propranolol among patients undergoing percutaneous coronary intervention (PCI) also treated with glycoprotein (GP) IIb/IIIa inhibitors.